Dietary sphingomyelin suppresses intestinal cholesterol absorption by decreasing thermodynamic activity of cholesterol monomers.
OBJECTIVE
In humans, cholesterol absorbed from the intestine contributes appreciably to serum cholesterol levels. We hypothesized that cholesterol thermodynamic activity (A(t)) would predict bioavailability of cholesterol monomers in intestinal content, and that natural dietary phospholipids exhibiting high affinity for cholesterol would reduce its absorption.


METHODS
Cholesterol A(t) was determined by measuring partitioning of monomeric cholesterol from aqueous solutions of taurocholate, cholesterol, and either milk sphingomyelin (MSM), dipalmitoyl phosphatidylcholine (DPPC), or egg yolk phosphatidylcholine (EYPC) into wafers of polymerized silicone. Cholesterol absorption from the same mixtures was tested with monolayers of Caco-2 cells. For in vivo absorption studies (employing male C57L/J mice), we used the fecal dual isotope method during dietary enrichment with MSM, DPPC, or EYPC at varying dose levels.


RESULTS
Cholesterol A(t) values were reduced significantly in MSM- and DPPC-containing systems compared with EYPC and correlated positively with reduced uptake and esterification of cholesterol by Caco-2 cells. Mice fed chow absorbed 31.4% +/- 6.9% (mean +/- SEM) cholesterol, whereas enrichment with MSM or DPPC led to dose-dependent decreases in cholesterol absorption; even at 0.1% MSM, cholesterol absorption was reduced by 20.4% +/- 15.4% (P < 0.05, n = 6).


CONCLUSIONS
Different phospholipids have distinct effects on micellar cholesterol A(t), which predicts cholesterol uptake by enterocytes in vitro as well as in vivo. Natural phospholipids with high affinity for cholesterol, as evidenced particularly by sphingomyelin, decrease A(t) and curtail intestinal cholesterol absorption.
Eckhardt
Erik R M
ER
Gastroenterology Division of Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Wang
David Q-H
DQ
Donovan
Joanne M
JM
Carey
Martin C
MC
D015060:1,2-Dipalmitoylphosphatidylcholine / Q000494:pharmacology; D000821:Animal Feed; D000818:Animals; D018938:Caco-2 Cells; D002784:Cholesterol / Q000737:chemistry* / Q000493:pharmacokinetics*; D004305:Dose-Response Relationship, Drug; D004530:Egg Yolk; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008823:Micelles; D008892:Milk; D010713:Phosphatidylcholines / Q000494:pharmacology; D013109:Sphingomyelins / Q000494:pharmacology*; D013816:Thermodynamics
D008823:Micelles; D010713:Phosphatidylcholines; D013109:Sphingomyelins; D015060:1,2-Dipalmitoylphosphatidylcholine; D002784:Cholesterol